Skip to main content

NASDAQ:RCKT Stock Forecast, Price Targets (Buy or Sell) | RCKT Rocket Pharmaceuticals Analyst Ratings



Shared facilities with captive finance entities. When an issuer has a shared revolving credit facility with a captive finance entity, for purposes of calculating the issuer's liquidity sources, we net outstanding commercial paper at the captive from the revolver's borrowing availability. In these cases, we generally use an estimate of peak CP borrowings at the captive to avoid potentially overstating sources available to the issuer over a 12- to 24-month period.

We estimate RCKT Rocket Pharmaceuticals stock forecast parameters by: Money Flow Index (MFI) with ANOVA



RCKT Rocket Pharmaceuticals Stock Forecast (Buy or Sell) as of 19 Apr 2022 for (n+6m)

Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network with Money Flow Index (MFI) and ANOVA. Machine Learning based stock forecast (n+6m) for RCKT Rocket Pharmaceuticals as below:

Time series to forecast n: 19 Apr 2022 for (n+6m)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %


 *AC Investment Research | Legal Disclaimer | NYSE | NASDAQ | LSE | NSE |